Vancomycin tolerance, a potential mechanism for refractory gram-positive bacteremia observational study in patients with cancer (Q40483972)

20 September 2017

Vancomycin tolerance, a potential mechanism for refractory gram-positive bacteremia observational study in patients with cancer (English)

1 reference

20 September 2017

gram-positive bacteria

0 references

1 reference

Kenneth V. I. Rolston

series ordinal

2

object named as

Kenneth V I Rolston

1 reference

20 September 2017

Amar Safdar

1

1 reference

PubMed ID

16534785

20 September 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

20 September 2017

1 reference

20 September 2017

106

1 reference

20 September 2017

8

1 reference

20 September 2017

1815-1820

1 reference

Penicillin tolerance in multiply drug-resistant natural isolates of Streptococcus pneumoniae.

20 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

7 January 2021

Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

7 January 2021

Bacteremia due to viridans streptococci in neutropenic patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

7 January 2021

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

7 January 2021

Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

7 January 2021

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

7 January 2021

Antimicrobial activity of gatifloxacin compared to seven other compounds tested against gram-positive organisms isolated at 10 cancer-treatment centers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

7 January 2021

Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

7 January 2021

Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

7 January 2021

Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

7 January 2021

Multiple antibiotic resistance in a bacterium with suppressed autolytic system.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

7 January 2021

Emergence of vancomycin tolerance in Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

7 January 2021

Glycopeptide tolerance in bacteria causing endocarditis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

7 January 2021

Antimicrobial tolerance in group C and group G streptococci

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

7 January 2021

Glycopeptide tolerance in Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

7 January 2021

The murMN operon: a functional link between antibiotic resistance and antibiotic tolerance in Streptococcuspneumoniae

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

7 January 2021

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

7 January 2021

Signal transduction by a death signal peptide: uncovering the mechanism of bacterial killing by penicillin.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

7 January 2021

Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

7 January 2021

Infectious morbidity in critically ill patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21801

7 January 2021

Identifiers

DOI

10.1002/CNCR.21801

1 reference

20 September 2017

1 reference

PubMed ID

16534785